Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxyapatite–DNA surface adsorption is a physicochemical process involving the binding of deoxyribonucleic acid (DNA) to the surface of hydroxyapatite (HAp), a crystalline calcium phosphate mineral that is the primary inorganic constituent of vertebrate bone and teeth [1]. This interaction is primarily driven by electrostatic attractions between the negatively charged phosphate groups of the DNA backbone and the positively charged calcium ions (C-sites) on the HAp crystal lattice, often supplemented by hydrogen bonding [2]. While not a traditional therapeutic target such as a protein receptor or enzyme, this adsorption phenomenon is extensively utilized in biotechnology for the purification of nucleic acids via hydroxyapatite chromatography [3]. In regenerative medicine and gene therapy, HAp nanoparticles serve as non-viral delivery vehicles, where the adsorption process allows for the stable loading and protection of therapeutic DNA or RNA against enzymatic degradation [4]. Furthermore, the affinity of DNA for hydroxyapatite surfaces is significant in environmental science and archaeology, as it facilitates the long-term preservation of ancient DNA within skeletal remains [5]. Understanding the kinetics and thermodynamics of this interaction is crucial for optimizing the efficiency of gene delivery systems and improving the biocompatibility of bone-integrated medical implants [6].
Electrostatic interaction between the negatively charged phosphate groups of the DNA backbone and the positively charged calcium ions (C-sites) on the hydroxyapatite surface.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyapatite–DNA surface adsorption (HAp-DNA adsorption).